Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-3339

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Atorvastatin Calcium is a prescription medication available in the form of tablets with 20 mg strength. The National Drug Code (NDC) for this medicine is 70518-3339-00. It is manufactured by Novadoz Pharmaceuticals LLC in Piscataway, New Jersey. This medication should be kept out of the reach of children. The expiry date and lot number are not available. To know how to use the medication, refer to the package insert. It should be stored at a temperature between 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) [See USP]. The medication is repackaged by RemedyRepack Inc., Indiana, PA 15701, and is available only on prescription.*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
The text is a graph showing the cumulative hazard percentage and the time to the first primary endpoint of a study through four years of follow-up. It also includes a hazard ratio of 0.63 with a confidence interval of 0.48 to 0.83 and a p-value of 0.001.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
The text is presenting data on the percentage of subjects experiencing an event, with the use of atorvastatin at different dosages. The dosage of 80mg resulted in a lower incidence of major cardiovascular endpoint over time. There is a Hazard Ratio (HR) value of 0.78 indicating a lower risk of cardiovascular events with the use of Atorvastatin 80mg, compared to a placebo or another dosage.*
FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.